[Other] CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).

camilo0595 Post time The day before yesterday 09:15 | Show all posts |Read mode

This post will be closed automatically in 2026-10-05 09:15

Reward20points

Revista: Journal of Clinical Oncology

Autores: Natasha B. Leighl; Scott Andrew Laurie; Glenwood D. Goss; Brett Gordon Maxwell Hughes; Martin R. Stockler; Ming Sound Tsao; Swati Kulkarni; Normand Blais; Anil A. Joy; Mihaela Mates; Punam Rana; Sunil Yadav; Craig Underhill; Christopher W. Lee; Penelope Ann Bradbury; Andrea Hiltz; Janet Dancey; Keyue Ding; Francisco Emilio Vera Badillo;

Fecha de publicación: 2020-05-20

DOI: 10.1200/jco.2020.38.15_suppl.9502

Enlace del artículo: https://doi.org/10.1200/jco.2020.38.15_suppl.9502

Fuente del artículo: Sociedad Estadounidense de Oncología Clínica (ASCO) .

Observación:

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report